Nucl Med Mol Imaging.
2019 Dec;53(6):436-441. 10.1007/s13139-019-00616-8.
Intramastoid Phosphaturic Mesenchymal Tumor Causing Hypophosphatemic Osteomalacia Detected on â¶â¸Ga-DOTATATE PET/CT But Not on (99m)Tc-Sestamibi and ¹â¸F-FDG Scans
- Affiliations
-
- 1Rheumatology Division, Hospital das ClÃnicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
- 2Nuclear Medicine Division, Hospital das ClÃnicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil. psduarte@hotmail.com
- 3Nuclear Medicine Section, São Paulo Cancer Institute (ICESP), Av. Dr. Arnaldo, 251, 4° SS Cerqueira César, São Paulo, SP 01246-000, Brazil.
- KMID: 2469588
- DOI: http://doi.org/10.1007/s13139-019-00616-8
Abstract
- â¶â¸Ga-DOTATATE uptake in mesenchymal tumors causing hypophosphatemic osteomalacia has been recently described. Herein, we present a case of â¶â¸Ga-DOTATATE uptake in an intramastoid phosphaturic mesenchymal tumor that had not been depicted in previous (99m)Tc-Sestamibi and ¹â¸F-FDG scans. The lesion was surgically removed and the phosphorus level increased to the normal range.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful Localization Using â¶â¸Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma
- Using 18F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia
- Extended Whole‑body Ga‑68 DOTATATE PET‑CT in evaluating Tumour‑Induced Osteomalacia: Case report and review of literature
- Discordant Molecular Imaging Findings with 2‑[18F]FDG and [68Ga] Ga‑PSMA PET/CT in a Patient with Both Bladder and Prostate Cancer
- Ga68-DOTA Peptide PET/CT to Detect Occult Mesenchymal Tumor-Inducing Osteomalacia: A Case Series of Three Patients
